During the past decade, Illinois Lung and Critical Care Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois Lung and Critical Care Institute" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Cephalon" with 2 trials sponsored, "Aeris Therapeutics" with 1 trials sponsored, "Agennix" with 1 trials sponsored and "Altor BioScience" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Lung and Critical Care Institute" #1 collaborator was "PneumRx, Inc." with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Illinois Lung and Critical Care Institute" are "Emphysema" (2 trials), "Acute Lung Injury" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Chronic Shift Work Sleep Disorder" (1 trials) and "Cystic Fibrosis" (1 trials). Many other conditions were trialed in "Illinois Lung and Critical Care Institute" in a lesser frequency.

Most popular intervention types in "Illinois Lung and Critical Care Institute" are "Drug" (6 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ALT-836" (1 trials), "Armodafinil 100 to 250 mg/day" (1 trials), "Desirudin" (1 trials) and "Inhaled mannitol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Illinois Lung and Critical Care Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Illinois Lung and Critical Care Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Illinois Lung and Critical Care Institute, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois Lung and Critical Care Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".